Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Thomas

Showing results (1231-1240 of 1,275) with videos related to

Pageof 128
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 3, 2024
Enhancing Precision in Detecting Severe Immune-Related Adverse Events: Comparative Analysis of Large Language Models and International Classification of Disease Codes in Patient RecordsVirginia H Sun, Julius C Heemelaar, Ibrahim Hadzic, et al.
Blood Cancer Discovery|November 8, 2022
Distinct Genetically Determined Origins of Myd88/BCL2-Driven Aggressive Lymphoma Rationalize Targeted Therapeutic Intervention StrategiesRuth Flümann, Julia Hansen, Benedikt W Pelzer, et al.
The Journal of Clinical Investigation|July 1, 2021
SARS-CoV-2 viremia is associated with distinct proteomic pathways and predicts COVID-19 outcomesYijia Li, Alexis M Schneider, Arnav Mehta, et al.
Medrxiv : the Preprint Server for Health Sciences|March 3, 2021
SARS-CoV-2 Viremia is Associated with Distinct Proteomic Pathways and Predicts COVID-19 OutcomesYijia Li, Alexis M Schneider, Arnav Mehta, et al.
Blood|April 7, 2016
B-cell-specific conditional expression of Myd88p.L252P leads to the development of diffuse large B-cell lymphoma in miceGero Knittel, Paul Liedgens, Darya Korovkina, et al.
Journal for Immunotherapy of Cancer|September 21, 2021
Effect of a multidisciplinary Severe Immunotherapy Complications Service on outcomes for patients receiving immune checkpoint inhibitor therapy for cancerLeyre Zubiri, Gabriel E Molina, Meghan J Mooradian, et al.
Biorxiv : the Preprint Server for Biology|October 13, 2021
Longitudinal characterization of circulating neutrophils uncovers distinct phenotypes associated with disease severity in hospitalized COVID-19 patientsThomas J LaSalle, Anna L K Gonye, Samuel S Freeman, et al.
The Oncologist|March 3, 2021
Temporal Trends and Outcomes Among Patients Admitted for Immune-Related Adverse Events: A Single-Center Retrospective Cohort Study from 2011 to 2018Gabriel E Molina, Leyre Zubiri, Justine V Cohen, et al.
Immunity|April 28, 2019
Enzymatic Activity of HPGD in Treg Cells Suppresses Tconv Cells to Maintain Adipose Tissue Homeostasis and Prevent Metabolic DysfunctionLisa Schmidleithner, Yasser Thabet, Eva Schönfeld, et al.
Biorxiv : the Preprint Server for Biology|October 4, 2023
Immune Responses in Checkpoint Myocarditis Across Heart, Blood, and TumorSteven M Blum, Daniel A Zlotoff, Neal P Smith, et al.
Pageof 128

Showing results (1231-1240 of 1,275) with videos related to

Sort By:
Pageof 128
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 3, 2024
Enhancing Precision in Detecting Severe Immune-Related Adverse Events: Comparative Analysis of Large Language Models and International Classification of Disease Codes in Patient RecordsVirginia H Sun, Julius C Heemelaar, Ibrahim Hadzic, et al.
Blood Cancer Discovery|November 8, 2022
Distinct Genetically Determined Origins of Myd88/BCL2-Driven Aggressive Lymphoma Rationalize Targeted Therapeutic Intervention StrategiesRuth Flümann, Julia Hansen, Benedikt W Pelzer, et al.
The Journal of Clinical Investigation|July 1, 2021
SARS-CoV-2 viremia is associated with distinct proteomic pathways and predicts COVID-19 outcomesYijia Li, Alexis M Schneider, Arnav Mehta, et al.
Medrxiv : the Preprint Server for Health Sciences|March 3, 2021
SARS-CoV-2 Viremia is Associated with Distinct Proteomic Pathways and Predicts COVID-19 OutcomesYijia Li, Alexis M Schneider, Arnav Mehta, et al.
Blood|April 7, 2016
B-cell-specific conditional expression of Myd88p.L252P leads to the development of diffuse large B-cell lymphoma in miceGero Knittel, Paul Liedgens, Darya Korovkina, et al.
Journal for Immunotherapy of Cancer|September 21, 2021
Effect of a multidisciplinary Severe Immunotherapy Complications Service on outcomes for patients receiving immune checkpoint inhibitor therapy for cancerLeyre Zubiri, Gabriel E Molina, Meghan J Mooradian, et al.
Biorxiv : the Preprint Server for Biology|October 13, 2021
Longitudinal characterization of circulating neutrophils uncovers distinct phenotypes associated with disease severity in hospitalized COVID-19 patientsThomas J LaSalle, Anna L K Gonye, Samuel S Freeman, et al.
The Oncologist|March 3, 2021
Temporal Trends and Outcomes Among Patients Admitted for Immune-Related Adverse Events: A Single-Center Retrospective Cohort Study from 2011 to 2018Gabriel E Molina, Leyre Zubiri, Justine V Cohen, et al.
Immunity|April 28, 2019
Enzymatic Activity of HPGD in Treg Cells Suppresses Tconv Cells to Maintain Adipose Tissue Homeostasis and Prevent Metabolic DysfunctionLisa Schmidleithner, Yasser Thabet, Eva Schönfeld, et al.
Biorxiv : the Preprint Server for Biology|October 4, 2023
Immune Responses in Checkpoint Myocarditis Across Heart, Blood, and TumorSteven M Blum, Daniel A Zlotoff, Neal P Smith, et al.
Pageof 128